Research Solutions Inc (RSSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,641 | 10,680 | 10,871 | 11,004 | 11,234 |
| Receivables | 5,622 | 4,618 | 4,703 | 4,718 | 5,013 |
| TOTAL | $17,560 | $16,279 | $16,047 | $16,897 | $17,307 |
| Non-Current Assets | |||||
| PPE Net | 44 | 41 | 21 | 21 | 15 |
| Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $45 | $42 | $22 | $22 | $16 |
| Total Assets | $17,605 | $16,321 | $16,069 | $16,919 | $17,323 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,084 | 6,515 | 6,462 | 6,687 | 7,558 |
| TOTAL | $12,427 | $11,256 | $10,900 | $11,492 | $12,160 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,343 | 4,741 | 4,439 | 4,804 | 4,602 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,427 | $11,256 | $10,900 | $11,492 | $12,160 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,064 | 27,103 | 26,744 | 26,615 | 26,352 |
| Common Shares | 27 | 27 | 27 | 27 | 26 |
| Retained earnings | -22,656 | -22,316 | -21,834 | -21,462 | -21,373 |
| Other shareholders' equity | -121 | -122 | -123 | -120 | -122 |
| TOTAL | $5,178 | $5,065 | $5,169 | $5,427 | $5,164 |
| Total Liabilities And Equity | $17,605 | $16,321 | $16,069 | $16,919 | $17,323 |